These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33829742)

  • 1. Comparison of different inflation times on the angiographic image after balloon angioplasty in the femoropopliteal segment: a prospective randomized clinical trial.
    Elens M; Colle A; Verhelst R; Astarci P
    J Cardiovasc Surg (Torino); 2021 Aug; 62(4):364-368. PubMed ID: 33829742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Prolonged Inflation Times During Plain Balloon Angioplasty on Angiographic Dissection in Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Kato S; Inoue N
    J Endovasc Ther; 2018 Dec; 25(6):683-691. PubMed ID: 30203701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Patient and Lesion Characteristics on Drug-Coated Balloon Angioplasty in the Femoropopliteal Artery: A Pooled Analysis of Four Randomized Controlled Multicenter Trials.
    Albrecht T; Ukrow A; Werk M; Tepe G; Zeller T; Meyer DR; Kutschera M; Speck U; Waliszewski M
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):495-504. PubMed ID: 30539236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty of Chronic Femoropopliteal Occlusions.
    Tan M; Urasawa K; Koshida R; Haraguchi T; Kitani S; Igarashi Y; Sato K
    J Endovasc Ther; 2018 Apr; 25(2):192-200. PubMed ID: 29429382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of the "Non-Slip Element" Percutaneous Transluminal Angioplasty Balloon in the Treatment of Femoropopliteal Arterial Lesions.
    Karashima E; Yoda S; Yasuda S; Kajiyama S; Ito H; Kaneko T
    J Endovasc Ther; 2020 Feb; 27(1):102-108. PubMed ID: 31724469
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics.
    Du X; Wang F; Wu DM; Zhang MH; Jia X; Zhang JW; Zhuang BX; Zhao Y; Guo PF; Bi W; Fu WG; Guo W; Wang SM
    Medicine (Baltimore); 2019 Mar; 98(13):e14840. PubMed ID: 30921183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of paclitaxel-coated balloon angioplasty with femoropopliteal bypass surgery in treating femoropopliteal lesions.
    Kavala AA; Kuserli Y; Turkyilmaz S
    Vascular; 2021 Apr; 29(2):260-269. PubMed ID: 32838692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
    Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2020 Jun; 27(3):481-491. PubMed ID: 32249658
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of angiography and intravascular ultrasound before and after balloon angioplasty of the femoropopliteal artery.
    van Lankeren W; Gussenhoven EJ; Pieterman H; van Sambeek MR; van der Lugt A
    Cardiovasc Intervent Radiol; 1998; 21(5):367-74. PubMed ID: 9853141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterolateral Popliteal Puncture Technique: A Novel Retrograde Approach for Chronic Femoropopliteal Occlusions.
    Tan M; Urasawa K; Koshida R; Haraguchi T; Kitani S; Igarashi Y; Sato K
    J Endovasc Ther; 2017 Aug; 24(4):525-530. PubMed ID: 28587565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of prolonged dilation to improve long-term patency of femoropopliteal artery angioplasty: results of a prospective trial.
    Söder HK; Manninen HI; Räsänen HT; Kaukanen E; Jaakkola P; Matsi PJ
    J Vasc Interv Radiol; 2002 Apr; 13(4):361-9. PubMed ID: 11932366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laser-assisted balloon angioplasty of occlusions in the femoropopliteal segment].
    Eiberg JP; Rasmussen JB; Schroeder TV
    Ugeskr Laeger; 1995 May; 157(20):2840-3. PubMed ID: 7785098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic and Clinical Outcomes After Treatment of Femoro-Popliteal Lesions with a Novel Paclitaxel-Matrix-Coated Balloon Catheter.
    Tepe G; Gögebakan Ö; Redlich U; Tautenhahn J; Ricke J; Halloul Z; Meyer DR; Waliszewski M; Schnorr B; Zeller T; Müller-Hülsbeck S; Ott I; Albrecht T
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1535-1544. PubMed ID: 28660441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year results of primary stenting for TASC II D lesions of the superficial femoral and popliteal arteries.
    Astarcıoglu MA; Kılıt C; Sen T; Durmus HI; Kalcık M; Gursoy MO; Yesın M; Asarcıklı LD; Gozubuyuk G; Amasyalı B
    Acta Cardiol; 2017 Feb; 72(1):36-40. PubMed ID: 28597743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.
    Zeller T; Brechtel K; Meyer DR; Noory E; Beschorner U; Albrecht T
    J Endovasc Ther; 2020 Oct; 27(5):683-690. PubMed ID: 32666871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.